Paradigm Biopharmaceuticals Ltd.ASX: PAR

PAR Expanded Access IND Cleared by US FDA

Sep 10, 2019 at 4:53 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment